CN104306441A - Traditional Chinese medicine oral solution for treating swine influenza and preparation method thereof - Google Patents
Traditional Chinese medicine oral solution for treating swine influenza and preparation method thereof Download PDFInfo
- Publication number
- CN104306441A CN104306441A CN201410536934.7A CN201410536934A CN104306441A CN 104306441 A CN104306441 A CN 104306441A CN 201410536934 A CN201410536934 A CN 201410536934A CN 104306441 A CN104306441 A CN 104306441A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- chinese medicine
- oral liquid
- swine influenza
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 29
- 206010069767 H1N1 influenza Diseases 0.000 title claims abstract description 27
- 208000009620 Orthomyxoviridae Infections Diseases 0.000 title claims abstract description 27
- 201000010740 swine influenza Diseases 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims description 11
- 229940100688 oral solution Drugs 0.000 title abstract 4
- 239000010231 banlangen Substances 0.000 claims abstract description 16
- 239000007788 liquid Substances 0.000 claims description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 3
- 229920000053 polysorbate 80 Polymers 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 7
- 241000700605 Viruses Species 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 4
- 206010059866 Drug resistance Diseases 0.000 abstract description 3
- 239000003640 drug residue Substances 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 229910052602 gypsum Inorganic materials 0.000 abstract 1
- 239000010440 gypsum Substances 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 241000282898 Sus scrofa Species 0.000 description 21
- 230000001225 therapeutic effect Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 241000725681 Swine influenza virus Species 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 241000712431 Influenza A virus Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- 241001466460 Alveolata Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 241001500343 Influenzavirus C Species 0.000 description 1
- 206010028116 Mucosal inflammation Diseases 0.000 description 1
- 201000010927 Mucositis Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 208000008423 pleurisy Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine oral solution for treating swine influenza. The oral solution is prepared from the following components in parts by weight: 10-20 parts of radix bupleuri, 5-20 parts of scutellaria baicalensis, 5-20 parts of radix isatidis, 5-15 parts of dandelion, 10-30 parts of folium isatidis, 5-20 parts of licorice root and 5-10 parts of gypsum. The traditional Chinese medicine oral solution has the effects of clearing heat, removing toxicity, diminishing inflammation and resisting viruses, has small toxic and side effect, cannot easily generate drug resistance, and has the advantages of high bioavailability and no drug residue.
Description
Technical field
The invention belongs to field of veterinary, especially a kind of Chinese medicine oral liquid for the treatment of swine influenza and preparation method thereof.
Background technology
Swine influenza is that the one of pig is acute, infectiousness respiratory illness.It is characterized by burst, cough, dyspnea, generate heat and lapse to rapidly.Swine flue is the respiratory system disease that pig body endogenous cause of ill virus causes.Swine flue is caused by influenza A virus (influenza A), usually breaks out between pig, and infectiousness is very high but usually can not cause death.Autumn and winter belongs to the high-incidence season, but the whole year can propagate.One of swine flue is recognized as influenza virus C (C type influenza virus) more, or the subspecies of influenza A virus.This virus can cause Influenza Outbreak in swinery.
The sickness rate of this disease is high, and incubation period is 2 ~ 7 days, the course of disease about 1 week.Sick pig their early stage generates heat suddenly, lassitude, loss of appetite or absolutely useless, and normal accumbency together, is reluctant activity, and dyspnea, fierce cough, eye nose flows out mucus.If in period of disease treatment not in time, then easy concurrent bronchitis, pneumonia and pleuritis etc., increase the case fatality rate of pig.Sick temperature of pig body raises and reaches 40 DEG C ~ 41.5 DEG C, and spirit is depressed, loss of appetite or do not eat, myalgia, is reluctant to stand, and eye and nose have viscous liquid to flow out, conjunctival congestion, indivedual sick pig dyspnea, breathes, cough, in ventral breathing, there is sitting position of dog gesture, disease pig whoop can be heard at night, indivedual sick pig arthralgia, especially the morbidity of the growth of livestock good pig is more serious.Cuing open inspection visible larynx, trachea and bronchus is full of containing alveolate mucus, and mucosa is congested, swelling, time and be mixed with blood, interstitial lung is broadening, lymphadenectasis, congested, splenomegaly, gastrointestinal mucosa has mucositis hemorrhagic inflammation, the liquid of splanchnocoel, pericardial cavity accumulation cellulose-containing mass.
At present, swine influenza causes damage comparatively large to pig industry clinically, and the antiviral agents of Western medicine mostly is violated medicine, cannot apply clinically.In addition, the effect of chemical medicine is unstable, easily affects treatment time adversely.Because the variability of virus is comparatively strong, the preparation of vaccine is difficult to the variation of catching up with virus.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine oral liquid for the treatment of swine influenza, this oral liquid has heat clearing away, removing toxic substances, antiinflammatory, antiviral effect, and toxic and side effects is little, not easily produces drug resistance, and bioavailability is high, drug residue free.
Another object of the present invention is to provide a kind of preparation method for the treatment of the Chinese medicine oral liquid of swine influenza.
The present invention is achieved through the following technical solutions:
Treat a Chinese medicine oral liquid for swine influenza, component and the ratio of weight and number thereof of its oral liquid are respectively: Radix Bupleuri 10-20 part; Radix Scutellariae 5-20 part; Radix Isatidis 5-20 part; Herba Taraxaci 5-15 part; Folium Isatidis 10-30 part; Radix Glycyrrhizae 5-20 part; Gypsum Fibrosum 5-10 part.
And component and the optimum ratio of weight and number thereof of this oral liquid are respectively: Radix Bupleuri 15 parts; Radix Scutellariae 13 parts; Radix Isatidis 12 parts; Herba Taraxaci 10 parts; Folium Isatidis 20 parts; 16 parts, Radix Glycyrrhizae; Gypsum Fibrosum 7 parts.
Treat a preparation method for the Chinese medicine oral liquid of swine influenza, the steps include:
(1) take Radix Bupleuri, Radix Scutellariae, Radix Isatidis, Herba Taraxaci, Folium Isatidis, Radix Glycyrrhizae and Gypsum Fibrosum respectively by weight ratio, roguing, weigh after add respectively in super micron mill machine and pulverize;
(2) decoct three times after the Radix Bupleuri after pulverizing in step (1), Radix Scutellariae, Radix Isatidis, Herba Taraxaci, Folium Isatidis, Radix Glycyrrhizae and Gypsum Fibrosum being added 3.5 times of water soaking 5-8 hours, each about 30-60min, filtration obtains filtrate A, and collects recrement, for subsequent use;
(3) recrement after step (2) being filtered adds 3-8 times amount clear water, boils rear 20-30min at a simmer, filters and obtains liquor B, for subsequent use;
(4) merging filtrate A and liquor B, filter, being concentrated into relative density is 1.01-1.03, adds 95% ethanol, makes alcohol content reach 40%, stirs evenly, and leaves standstill 24 hours, filters, and reclaims ethanol to without alcohol taste, adds suitable quantity of water, centrifuging and taking supernatant, for subsequent use;
(5) in the supernatant of step (4) gained, add ethanol and the 4-6% tween 80 of 35-40%, stir evenly, filter, subpackage, sterilizing, the Chinese medicine oral liquid finished product of swine influenza must be treated.
Advantage of the present invention and beneficial effect are:
The Radix Bupleuri contained in the Chinese medicine oral liquid of 1, this treatment swine influenza, Radix Scutellariae, Radix Isatidis, Herba Taraxaci, Folium Isatidis, the Chinese medicinal ingredients such as Radix Glycyrrhizae and Gypsum Fibrosum, there is good preventive and therapeutic effect, antivirus action successful to the respiratory tract disease that antibacterial and virus cause.
2, the present invention contains the 7 taste Chinese medicines such as Radix Bupleuri, Radix Scutellariae, Radix Isatidis, Herba Taraxaci, Folium Isatidis, Radix Glycyrrhizae and Gypsum Fibrosum, pulverizes, be conducive to the raising of herbal medicine efficacy through super micron mill.By the compatibility of Chinese medicinal formulae, greatly can improve the curative effect of said composition, improve body disease-resistant power.
3, the Chinese medicine oral liquid of this treatment swine influenza have taking dose little, delicious, absorb fast, prove effective rapidly, steady quality, be easy to carry, be easy to the advantages such as preservation.
4, the present invention has heat clearing away, removing toxic substances, antiinflammatory, cough-relieving, antiviral effect, have no side effect little, not easily produce drug resistance, bioavailability is high, drug residue free, meeting safe veterinary drug, ensure the requirement of animal-derived food safety, is a kind of Chinese medicine oral liquid of ideal treatment swine influenza.
Detailed description of the invention
The present invention is described in further detail by following examples.It should be noted that: following embodiment is illustrative, is not determinate, can not limit protection scope of the present invention with following embodiment.
Embodiment 1
Treat a Chinese medicine oral liquid for swine influenza, component and the weight thereof of its Chinese medicine oral liquid are respectively: Radix Bupleuri 100g; Radix Scutellariae 100g; Radix Isatidis 150g; Herba Taraxaci 100g; Folium Isatidis 100g; Radix Glycyrrhizae 100g; Gypsum Fibrosum 50g.
Treat a preparation method for the Chinese medicine oral liquid of swine influenza, its step is as follows:
(1) take Radix Bupleuri, Radix Scutellariae, Radix Isatidis, Herba Taraxaci, Folium Isatidis, Radix Glycyrrhizae and Gypsum Fibrosum respectively by weight ratio, roguing, weigh after add respectively in super micron mill machine and pulverize;
(2) decoct three times after the Radix Bupleuri after pulverizing in step (1), Radix Scutellariae, Radix Isatidis, Herba Taraxaci, Folium Isatidis, Radix Glycyrrhizae and Gypsum Fibrosum being added 3.5 times of water soaking 5-8 hours, each about 30-60min, filtration obtains filtrate A, and collects recrement, for subsequent use;
(3) recrement after step (2) being filtered adds 3-8 times amount clear water, boils rear 20-30min at a simmer, filters and obtains liquor B, for subsequent use;
(4) merging filtrate A and liquor B, filter, being concentrated into relative density is 1.01-1.03, adds 95% ethanol, makes alcohol content reach 40%, stirs evenly, and leaves standstill 24 hours, filters, and reclaims ethanol to without alcohol taste, adds suitable quantity of water, centrifuging and taking supernatant, for subsequent use;
(5) in the supernatant of step (4) gained, add ethanol and the 4-6% tween 80 of 35-40%, stir evenly, filter, subpackage, sterilizing, the Chinese medicine oral liquid finished product of swine influenza must be treated.
Embodiment 2
Treat a Chinese medicine oral liquid for swine influenza, component and the weight thereof of its Chinese medicine oral liquid are respectively: Radix Bupleuri 200g; Radix Scutellariae 300g; Radix Isatidis 200g; Herba Taraxaci 200g; Folium Isatidis 100g; Radix Glycyrrhizae 80g; Gypsum Fibrosum 100g.
The step of its preparation method is with embodiment 1.
Embodiment 3
Treat a Chinese medicine oral liquid for swine influenza, component and the weight thereof of its Chinese medicine oral liquid are respectively: Radix Bupleuri 150g; Radix Scutellariae 250g; Radix Isatidis 200g; Herba Taraxaci 175g; Folium Isatidis 250g; Radix Glycyrrhizae 100g; Gypsum Fibrosum 100g.
The step of its preparation method is with embodiment 1.
Clinical practice
In order to verify the clinical therapeutic efficacy of the present invention to swine influenza, in the cultivation factory of certain infected pigs influenza virus of Dezhou City Shandong Province, carry out the clinical trial of the swine influenza that the present invention causes pig natural infection swine influenza virus.The present invention is divided into basic, normal, high three dosage to carry out grouping administration to animal by test, compares, thus evaluate therapeutic effect of the present invention and optimum amount with blank group.
1, materials and methods
1.1 experimental animal
There is the pig farm of swine influenza in Dezhou City Shandong Province, filters out ill pig 50 for subsequent use.
1.2 trial drug
The present invention is prepared by our company.
1.3 experimental animal groupings and process
The sick pig of abiogenous swine influenza is divided into 4 groups at random, often organizes 10.
In addition, 10 health pig of not falling ill are filtered out as normal healthy controls group.
1.4 result of the test
To the pig of natural infection swine influenza virus, give the oral liquid of various dose respectively, after mixed drink, by comparing with matched group, the clinical symptoms of morbidity pig obviously alleviates, and case fatality rate declines.Therapeutic effect and the recovery situation of middle dosage group all reach desirable requirement, substantially suitable with normal healthy controls group; The results are shown in following table.
Table 1 observation of curative effect
1.5 interpretation of result
From clinical symptoms, cut open inspection change, case fatality rate, cure rate four aspects analyze, the therapeutic effect of middle dosage group and high dose group is apparently higher than infecting matched group, and consider economic benefit, in final advisory the present invention, dosage carries out therapeutic effect the best.
1.6 conclusion
The present invention is by per kilogram of body weight 2mL administration, and mixed drink, treats the swinery of natural infection swine influenza virus, achieve good therapeutic effect for continuous 5 days.
Claims (3)
1. treat a Chinese medicine oral liquid for swine influenza, it is characterized in that: component and the ratio of weight and number thereof of this oral liquid are respectively: Radix Bupleuri 10-20 part; Radix Scutellariae 5-20 part; Radix Isatidis 5-20 part; Herba Taraxaci 5-15 part; Folium Isatidis 10-30 part; Radix Glycyrrhizae 5-20 part; Gypsum Fibrosum 5-10 part.
2. the Chinese medicine oral liquid for the treatment of swine influenza according to claim 1, is characterized in that: component and the optimum ratio of weight and number thereof of this oral liquid are respectively: Radix Bupleuri 15 parts; Radix Scutellariae 13 parts; Radix Isatidis 12 parts; Herba Taraxaci 10 parts; Folium Isatidis 20 parts; 16 parts, Radix Glycyrrhizae; Gypsum Fibrosum 7 parts.
3. a preparation method for the Chinese medicine oral liquid for the treatment of swine influenza as claimed in claim 1, is characterized in that: this preparation method step is:
(1) take Radix Bupleuri, Radix Scutellariae, Radix Isatidis, Herba Taraxaci, Folium Isatidis, Radix Glycyrrhizae and Gypsum Fibrosum respectively by weight ratio, roguing, weigh after add respectively in super micron mill machine and pulverize;
(2) decoct three times after the Radix Bupleuri after pulverizing in step (1), Radix Scutellariae, Radix Isatidis, Herba Taraxaci, Folium Isatidis, Radix Glycyrrhizae and Gypsum Fibrosum being added 3.5 times of water soaking 5-8 hours, each about 30-60min, filtration obtains filtrate A, and collects recrement, for subsequent use;
(3) recrement after step (2) being filtered adds 3-8 times amount clear water, boils rear 20-30min at a simmer, filters and obtains liquor B, for subsequent use;
(4) merging filtrate A and liquor B, filter, being concentrated into relative density is 1.01-1.03, adds 95% ethanol, makes alcohol content reach 40%, stirs evenly, and leaves standstill 24 hours, filters, and reclaims ethanol to without alcohol taste, adds suitable quantity of water, centrifuging and taking supernatant, for subsequent use;
(5) in the supernatant of step (4) gained, add ethanol and the 4-6% tween 80 of 35-40%, stir evenly, filter, subpackage, sterilizing, the Chinese medicine oral liquid finished product of swine influenza must be treated.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410536934.7A CN104306441A (en) | 2014-10-13 | 2014-10-13 | Traditional Chinese medicine oral solution for treating swine influenza and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410536934.7A CN104306441A (en) | 2014-10-13 | 2014-10-13 | Traditional Chinese medicine oral solution for treating swine influenza and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104306441A true CN104306441A (en) | 2015-01-28 |
Family
ID=52361850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410536934.7A Pending CN104306441A (en) | 2014-10-13 | 2014-10-13 | Traditional Chinese medicine oral solution for treating swine influenza and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104306441A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104940338A (en) * | 2015-06-17 | 2015-09-30 | 产俊涛 | Traditional Chinese medicine composition for treating SI (Swine influenza) and application thereof |
| CN105477065A (en) * | 2015-12-16 | 2016-04-13 | 宁风廷 | Method using Chinese herbal medicine to prevent influenza |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101361820A (en) * | 2008-09-17 | 2009-02-11 | 天津必佳药业集团有限公司 | Traditional Chinese medicine combination for clearing away the heat-evil and expelling superficial evils, bacterial resisting and diminishing inflammation, preventing asthma and relieving cough and pr |
| CN101380448A (en) * | 2007-09-05 | 2009-03-11 | 宫兆荣 | Traditional Chinese medicine for preventing and treating pig influenza |
| CN101983665A (en) * | 2010-09-20 | 2011-03-09 | 沁源县灵兴养殖专业合作社 | Traditional Chinese medicine for preventing swine influenza |
-
2014
- 2014-10-13 CN CN201410536934.7A patent/CN104306441A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101380448A (en) * | 2007-09-05 | 2009-03-11 | 宫兆荣 | Traditional Chinese medicine for preventing and treating pig influenza |
| CN101361820A (en) * | 2008-09-17 | 2009-02-11 | 天津必佳药业集团有限公司 | Traditional Chinese medicine combination for clearing away the heat-evil and expelling superficial evils, bacterial resisting and diminishing inflammation, preventing asthma and relieving cough and pr |
| CN101983665A (en) * | 2010-09-20 | 2011-03-09 | 沁源县灵兴养殖专业合作社 | Traditional Chinese medicine for preventing swine influenza |
Non-Patent Citations (1)
| Title |
|---|
| 黄金碧: ""柴胡葛根汤治外感发热症的临床体会"", 《中国中医药现代远程教育》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104940338A (en) * | 2015-06-17 | 2015-09-30 | 产俊涛 | Traditional Chinese medicine composition for treating SI (Swine influenza) and application thereof |
| CN105477065A (en) * | 2015-12-16 | 2016-04-13 | 宁风廷 | Method using Chinese herbal medicine to prevent influenza |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103191240B (en) | Traditional Chinese veterinary medicine oral solution for preventing and treating viral diseases of poultry | |
| CN101804162B (en) | Anti-newcastle disease virus Chinese medicinal composition and preparation method thereof | |
| CN104337976A (en) | Traditional Chinese medicine composition for improving immunity of beasts and birds | |
| CN104644757A (en) | Traditional Chinese medicine oral liquid for treating avian influenza and preparation method thereof | |
| CN104306441A (en) | Traditional Chinese medicine oral solution for treating swine influenza and preparation method thereof | |
| CN101069714A (en) | Medicine for preventing and treating fowl's respiratory tract diseases and preparing method | |
| CN105726742B (en) | A kind of traditional Chinese veterinary medicine against chicken Newcastle disease virus disease and avian influenza and preparation method thereof | |
| CN103006848B (en) | Antiviral Chinese herbal medicine compound preparation for birds | |
| CN101342301B (en) | A kind of medicine for preventing and treating mycoplasma gallisepticum | |
| CN105641368A (en) | Traditional Chinese medicinal composition for treating avian infectious laryngotracheitis and preparation method of traditional Chinese medicinal composition | |
| CN101279028B (en) | Method of preparing Oral liquid vaccine for preventing and controlling avian influenza of domestic animals and domestic birds | |
| CN109464521B (en) | Traditional Chinese medicine composition for preventing and treating chicken bronchial embolism | |
| CN108524746B (en) | Traditional Chinese medicine composition for preventing and treating poultry cold | |
| CN106237050A (en) | A kind of Chinese medicine compound of effective preventing and treating H1N1 and H3N2 swine flue and pig blue-ear disease and preparation method thereof | |
| CN101829257B (en) | Traditional Chinese medicine oral liquid for treating chicken colibacillosis and preparation method thereof | |
| CN104645273A (en) | Traditional Chinese medicine oral liquid for treating fowl cholera and preparation method thereof | |
| CN111544513A (en) | Medicine for preventing and treating avian viral diseases and preparation method thereof | |
| CN104840591A (en) | Traditional Chinese medicine composition with effect of preventing and treating Newcastle disease | |
| CN109481591A (en) | The Chinese medicine composition and preparation method thereof for treating curing gallinaceous leucocyto zoonosis | |
| CN104208168B (en) | A kind of for compound traditional Chinese medicine composite treating poultry respiratory infection and preparation method thereof | |
| CN109528994B (en) | Chaigui oral liquid and preparation method thereof | |
| CN103816199B (en) | A kind of anti-duck virus hepatitis Chinese medical extract compound | |
| CN106860689B (en) | Traditional Chinese medicine compound preparation for preventing and treating egg drop syndrome of chickens and preparation method thereof | |
| CN104547886A (en) | Traditional Chinese medicinal oral liquid for treating chicken cough and asthma and preparation method for traditional Chinese medicinal oral liquid | |
| CN114762705A (en) | Traditional Chinese medicine granules for preventing and treating chicken infectious bronchitis disease and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150128 |
|
| RJ01 | Rejection of invention patent application after publication |